Found: 32
Select item for more details and to access through your institution.
Preclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinib.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysis.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00055
- By:
- Publication type:
- Article
ABCG2: determining its relevance in clinical drug resistance.
- Published in:
- Cancer & Metastasis Reviews, 2007, v. 26, n. 1, p. 39, doi. 10.1007/s10555-007-9042-6
- By:
- Publication type:
- Article
Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Remote Home Monitoring of Patients with Cancer During the COVID-19 Pandemic.
- Published in:
- Oncology Issues, 2022, v. 37, n. 3, p. 20, doi. 10.1080/10463356.2022.2055427
- By:
- Publication type:
- Article
3397 Genetic variants in gestational diabetes mellitus.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 1, p. 31, doi. 10.1023/B:DRUG.0000047103.64335.b0
- By:
- Publication type:
- Article
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 6, p. 1944, doi. 10.1002/cam4.3672
- By:
- Publication type:
- Article
RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The 315–316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant.
- Published in:
- Molecular & Cellular Biochemistry, 2009, v. 322, n. 1/2, p. 63, doi. 10.1007/s11010-008-9940-0
- By:
- Publication type:
- Article
Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
- Published in:
- Biomedical Chromatography, 2012, v. 26, n. 11, p. 1315, doi. 10.1002/bmc.2697
- By:
- Publication type:
- Article
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I study of oral ixabepilone in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1071, doi. 10.1007/s00280-014-2443-7
- By:
- Publication type:
- Article
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 729, doi. 10.1007/s00280-014-2399-7
- By:
- Publication type:
- Article
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 627, doi. 10.1007/s00280-012-2048-y
- By:
- Publication type:
- Article
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 6, p. 843, doi. 10.1007/s00280-012-1969-9
- By:
- Publication type:
- Article
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 11, p. 1327, doi. 10.3390/cells8111327
- By:
- Publication type:
- Article
Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
- Published in:
- Head & Neck, 2015, v. 37, n. 10, p. 1403, doi. 10.1002/hed.23763
- By:
- Publication type:
- Article
Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2015, v. 37, n. 5, p. 630, doi. 10.1002/hed.23644
- By:
- Publication type:
- Article
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 10, p. 1645, doi. 10.1002/cncr.29224
- By:
- Publication type:
- Article
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 8, p. 1194, doi. 10.1002/cncr.28554
- By:
- Publication type:
- Article
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 21, p. 5403, doi. 10.1002/cncr.27526
- By:
- Publication type:
- Article
Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: to test or not to test, that is the question.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency.
- Published in:
- Human Mutation, 2018, v. 39, n. 1, p. 69, doi. 10.1002/humu.23345
- By:
- Publication type:
- Article
Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 730, doi. 10.1093/oncolo/oyad129
- By:
- Publication type:
- Article
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study.
- Published in:
- Oncologist, 2022, v. 27, n. 8, p. 623, doi. 10.1093/oncolo/oyac004
- By:
- Publication type:
- Article
Supportive Treatments for Oncology Patients: Not Just Icing on the Cake.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
The Rising Challenge of Non–AIDS-Defining Cancers in HIV-Infected Patients.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 9, p. 1228, doi. 10.1093/cid/cis613
- By:
- Publication type:
- Article
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061.
- Published in:
- Infectious Agents & Cancer, 2012, v. 7, n. Suppl 1, p. 1, doi. 10.1186/1750-9378-7-S1-O15
- By:
- Publication type:
- Article
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors.
- Published in:
- Clinical Proteomics, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12014-024-09476-7
- By:
- Publication type:
- Article